 natur histori congest gastropathi cirrhosi liver studi group cervello hospit prospect studi natur histori congest gastropathi consecut cirrhot patient sclerotherapi mean follow-up month mild gastropathi pattern patient sever gastropathi granular mucosa cherri spot preval helicobact pylori campylobact pylori patient mild sever gastropathi congest gastropathi frequent patient sclerotherapi sixty-month actuari proport patient free anemia absenc hematemesi melena sever mild gastropathi correspond figur overt bleed surviv multivari regress analysi follow conclus sclerotherapi presenc larg esophag varic risk congest gastropathi signific risk indic chronic overt bleed affect surviv